Revised HPUS Website to Launch in June

By Eric L. Foxman, Senior Scientist, HPCUS The revised and updated HPUS.com for the Homeopathic Pharmacopeia of the United States will tentatively be launched June 5. The newly designed website will continue to be…

Read More

The HPCUS Friends of the Pharmacopoeia Program

By Dr. William Shevin, President, HPCUS  Due to challenges in general for homeopathy and specifically for the Homeopathic Pharmacopoeia Convention of the United States (HPCUS), the standards-setting organization is launching…

Read More

What’s In a Name?

By Al Lorman, AAHP Counsel FDA’s issuance of its new guidance on homeopath drugs in December, 2022 has caused concern in some quarters because of the language used by the…

Read More

The Regulation of Homeopathic Drug Products

Statutory Recognition of Homeopathic Drugs   Since the passage of the Federal Food, Drug, and Cosmetic Act (FDCA) in 1938, homeopathic drugs are the only form of alternative or complementary medicine…

Read More

Regulation in Homeopathy

This month we will discuss policy outcomes from FDA’s policy and enforcement guidance documents past and present for homeopathic drug products.  In our first article, The Regulation of Homeopathic Drug…

Read More